189 related articles for article (PubMed ID: 28349284)
1. The Evolution of Tumor Formation in Humans and Mice with Inherited Mutations in the p53 Gene.
Levine AJ
Curr Top Microbiol Immunol; 2017; 407():205-221. PubMed ID: 28349284
[TBL] [Abstract][Full Text] [Related]
2. Cancer risks from germ line tumor suppressor gene mutations.
Frebourg T; Malkin D; Friend S
Princess Takamatsu Symp; 1991; 22():61-70. PubMed ID: 1844252
[TBL] [Abstract][Full Text] [Related]
3. The Role of the p53 Protein in Stem-Cell Biology and Epigenetic Regulation.
Levine AJ; Puzio-Kuter AM; Chan CS; Hainaut P
Cold Spring Harb Perspect Med; 2016 Sep; 6(9):. PubMed ID: 27352800
[TBL] [Abstract][Full Text] [Related]
4. Tumors associated with p53 germline mutations: a synopsis of 91 families.
Kleihues P; Schäuble B; zur Hausen A; Estève J; Ohgaki H
Am J Pathol; 1997 Jan; 150(1):1-13. PubMed ID: 9006316
[TBL] [Abstract][Full Text] [Related]
5. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.
Nichols KE; Malkin D; Garber JE; Fraumeni JF; Li FP
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):83-7. PubMed ID: 11219776
[TBL] [Abstract][Full Text] [Related]
6. New approaches to understanding p53 gene tumor mutation spectra.
Hollstein M; Hergenhahn M; Yang Q; Bartsch H; Wang ZQ; Hainaut P
Mutat Res; 1999 Dec; 431(2):199-209. PubMed ID: 10635987
[TBL] [Abstract][Full Text] [Related]
7. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.
Lang GA; Iwakuma T; Suh YA; Liu G; Rao VA; Parant JM; Valentin-Vega YA; Terzian T; Caldwell LC; Strong LC; El-Naggar AK; Lozano G
Cell; 2004 Dec; 119(6):861-72. PubMed ID: 15607981
[TBL] [Abstract][Full Text] [Related]
8. The Evolution of Tumors in Mice and Humans with Germline p53 Mutations.
Levine AJ; Chan CS; Dudgeon C; Puzio-Kuter A; Hainaut P
Cold Spring Harb Symp Quant Biol; 2015; 80():139-45. PubMed ID: 26642854
[TBL] [Abstract][Full Text] [Related]
9. Most spontaneous tumors in a mouse model of Li-Fraumeni syndrome do not have a mutator phenotype.
Hill KA; Buettner VL; Heidt A; Chen LL; Li W; Gonzalez KD; Wang JC; Scaringe WA; Sommer SS
Carcinogenesis; 2006 Sep; 27(9):1860-6. PubMed ID: 16597646
[TBL] [Abstract][Full Text] [Related]
10. [The mutational spectra of gene p53 in different types of tumors].
Glazko GV; Rogozin IB; Sozinov AA
Tsitol Genet; 1999; 33(3):14-20. PubMed ID: 10474858
[TBL] [Abstract][Full Text] [Related]
11. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms.
Malkin D; Jolly KW; Barbier N; Look AT; Friend SH; Gebhardt MC; Andersen TI; Børresen AL; Li FP; Garber J
N Engl J Med; 1992 May; 326(20):1309-15. PubMed ID: 1565144
[TBL] [Abstract][Full Text] [Related]
12. p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition.
Vahteristo P; Tamminen A; Karvinen P; Eerola H; Eklund C; Aaltonen LA; Blomqvist C; Aittomäki K; Nevanlinna H
Cancer Res; 2001 Aug; 61(15):5718-22. PubMed ID: 11479205
[TBL] [Abstract][Full Text] [Related]
13. Inherited p53 gene mutations in breast cancer.
Sidransky D; Tokino T; Helzlsouer K; Zehnbauer B; Rausch G; Shelton B; Prestigiacomo L; Vogelstein B; Davidson N
Cancer Res; 1992 May; 52(10):2984-6. PubMed ID: 1581912
[TBL] [Abstract][Full Text] [Related]
14. Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.
Frebourg T; Kassel J; Lam KT; Gryka MA; Barbier N; Andersen TI; Børresen AL; Friend SH
Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6413-7. PubMed ID: 1631137
[TBL] [Abstract][Full Text] [Related]
15. The Li-Fraumeni syndrome: an inherited susceptibility to cancer.
Evans SC; Lozano G
Mol Med Today; 1997 Sep; 3(9):390-5. PubMed ID: 9302689
[TBL] [Abstract][Full Text] [Related]
16. Contribution of p53, p63, and p73 to the developmental diseases and cancer.
Tomkova K; Tomka M; Zajac V
Neoplasma; 2008; 55(3):177-81. PubMed ID: 18348649
[TBL] [Abstract][Full Text] [Related]
17. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.
Srivastava S; Zou ZQ; Pirollo K; Blattner W; Chang EH
Nature; 1990 Dec 20-27; 348(6303):747-9. PubMed ID: 2259385
[TBL] [Abstract][Full Text] [Related]
18. p53 Testing for Li-Fraumeni and Li-Fraumeni-like syndromes.
Gonzalez K; Fong C; Buzin C; Sommer SS; Saldivar JS
Curr Protoc Hum Genet; 2008 Apr; Chapter 10():Unit 10.10. PubMed ID: 18428420
[TBL] [Abstract][Full Text] [Related]
19. 1995 Deichmann Lecture--p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology and cancer risk assessment.
Harris CC
Toxicol Lett; 1995 Dec; 82-83():1-7. PubMed ID: 8597035
[TBL] [Abstract][Full Text] [Related]
20. Use of p53 transgenic mice in the development of cancer models for multiple purposes.
Lubet RA; Zhang Z; Wiseman RW; You M
Exp Lung Res; 2000 Dec; 26(8):581-93. PubMed ID: 11195457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
